Globally, the industry is at the crossroads of many challenges and, at the same time, seeing new trends in technology that will help it break through some of the barriers that have previously held it back. Major scientific and technological advances, coupled with socio-demographic changes and increasing demand for medicines will revive the pharma industry’s fortunes in another 10 to 20 years.
The social, demographic and economic context in which the global pharmaceutical industry operates is changing. Developed economies with spiralling healthcare costs are looking to rein in healthcare expenditure. Payers are demanding a reimbursement model based on healthcare outcomes.